Torres-Netto EA, Abdshahzadeh H, Abrishamchi R, Hafezi NL, Hillen M, Ambrósio R Jr, Randleman JB, Spoerl E, Gatinel D, Hafezi F Reply: Ex Vivo Eye Rubbing Evidence J Refract Surg. 2022 Nov;38(11):752-753 PubMed Group Hafezi |
Abdshahzadeh H, Abrishamchi R, Aydemir ME, Hafezi N, Hillen M, Torres-Netto EA, Lu NJ, Hafezi F Repeated application of riboflavin during corneal cross-linking does not improve the biomechanical stiffening effect ex vivo Exp Eye Res. 2022 Nov;224:109267 PubMed Group Hafezi |
Hafezi F, Lu NJ, Assaf JF, Hafezi NL, Koppen C, Vinciguerra R, Vinciguerra P, Hillen M, Awwad ST Demarcation Line Depth in Epithelium-Off Corneal Cross-Linking Performed at the Slit Lamp J Clin Med. 2022 Oct 4;11(19):5873 PubMed Group Hafezi |
Hafezi F Corneal Cross-Linking: Epi-On Cornea. 2022 Oct 1;41(10):1203-1204 PubMed Group Hafezi |
Lu NJ, Hafezi F, Rozema JJ, Hillen M, Hafezi N, Zhang J, Koppen C Repeatability of a Scheimpflug tonometer to measure biomechanical parameters before and after myopic refractive surgery J Cataract Refract Surg. 2022 Sep 1;48(9):1057-1062 PubMed Group Hafezi |
Achiron A, Elhaddad O, Regev T, Krakauer Y, Tsumi E, Hafezi F, Knyazer B PACK Cross-Linking as Adjuvant Therapy Improves Clinical Outcomes in Culture-Confirmed Bacterial Keratitis Cornea. 2022 Sep 1;41(9):1069-1073 PubMed Group Hafezi |
Torres-Netto EA, Abdshahzadeh H, Abrishamchi R, Hafezi NL, Hillen M, Ambrósio R Jr, Randleman JB, Spoerl E, Gatinel D, Hafezi F The Impact of Repetitive and Prolonged Eye Rubbing on Corneal Biomechanics J Refract Surg. 2022 Sep;38(9):610-616 PubMed Group Hafezi |
Mazzotta C, Balamoun AA, Chabib A, Rechichi M, D`Oria F, Hafezi F, Bagaglia SA, Ferrise M Transepithelial Enhanced Fluence Pulsed Light M Accelerated Crosslinking for Early Progressive Keratoconus with Chemically Enhanced Riboflavin Solutions and Air Room Oxygen. J Clin Med. 2022 Aug 27;11(17):5039 PubMedGroup Hafezi |
Hafezi F, Munzinger A, Goldblum D, Hillen M, Tandogan T Repeated High-Fluence Accelerated Slitlamp-Based Photoactivated Chromophore for Keratitis Corneal Cross-Linking for Treatment-Resistant Fungal Keratitis Cornea. 2022 Aug 1;41(8):1058-1061 PubMed Group Hafezi |
Hafezi F, Hillen M, Kollros L, Tan J, Awwad ST A New Postoperative Regimen after CXL and PRK Using Topical NSAID and Steroids on the Open Ocular Surface J Clin Med. 2022 Jul 15;11(14):4109 PubMed Group Hafezi |
Torres-Netto EA, Hafezi F, Kling S Intracorneal Ring Segment Implantation Results in Corneal Mechanical Strengthening Visualized With Optical Coherence Elastography J Refract Surg. 2022 Jul;38(7):459-464 PubMed Group Hafezi |
Lu NJ, Elsheikh A, Rozema JJ, Hafezi N, Aslanides IM, Hillen M, Eckert D, Funck C, Koppen C, Cui LL, Hafezi F Combining Spectral-Domain OCT and Air-Puff Tonometry Analysis to Diagnose Keratoconus J Refract Surg. 2022 Jun;38(6):374-380 PubMed Group Hafezi |
Hashemi H, Roberts CJ, Ambrósio R Jr, Mehravaran S, Hafezi F, Vinciguerra R, Vinciguerra P, Panahi P, Asgari S Comparative Contralateral Randomized Clinical Trial of Standard (3 mW/cm2) Versus Accelerated (9 mW/cm2) CXL in Patients With Down Syndrome: 3-Year Results J Refract Surg. 2022 Jun;38(6):381-388 PubMedGroup Hafezi |
Torres-Netto EA, Kling S Corneal Strain Induced by Intracorneal Ring Segment Implantation Visualized With Optical Coherence Elastography J Refract Surg. 2022 Mar;38(3):210-216 PubMed Group Hafezi |
Burkard T, Holmberg D, Thorell A, Hafezi F, Burden AM The association between bariatric surgery and cataract: a propensity score-matched cohort study Surg Obes Relat Dis. 2022 Feb;18(2):217-224 PubMed Group Hafezi |
Hafezi F, Hosny M, Shetty R, Knyazer B, Chen S, Wang Q, Hashemi H, Torrs-Netto EA; PACK-CXL Workig Group PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Eye Vis (Lond). 2022 Jan 7;9(1):2 PubMed Group Hafezi |
Frese L, Darwiche SE, Gunning ME, Hoerstrup SP, von Rechenberg B, Giovanoli P, Calcagni M Optimizing large-scale autologous human keratinocyte sheets for major burns - Toward an animal-free production and a more accessible clinical application Health Sci Rep. 2022 Jan7;5(1):e449 PubMed Group Calcagni |
Hafezi F, Kling S, Gilardoni F, Hafezi N, Hillen M, Abrishamchi R, Gomes JAP, Mazzotta C, Randleman JB, Torres-Netto EA Reply to comment on: Individualized Corneal Cross-linking With Riboflavin and UV-A in Ultrathin Corneas: The Sub400 Protocol. Am J Ophthalmol. 2022 Jan;233:243-245 PubMed Group Hafezi |
Hafezi F, Hillen M, Kollros L, Hafezi NL, Torres-Netto EA Corneal Cross-linking in Thin Corneas: From Origins to State of the Art. touchREVIEWS in Ophthalmology. 2022;16(1):13-6 touch Ophthalmology Group Hafezi |